KDR and acute myeloid leukemia: Additionally, EGFR, CASP3, SRC, and KDR among the core targets have been reported to have high expression levels in AML with plasma concentrations of 88 μg/L, 94 ng/L, 3.2 μg/L, and 11 μg/L, respectively (Supplementary Figure S1).